Does POLATUZUMAB VEDOTIN-PIIQ Cause Hepatic function abnormal? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hepatic function abnormal have been filed in association with POLATUZUMAB VEDOTIN-PIIQ. This represents 0.8% of all adverse event reports for POLATUZUMAB VEDOTIN-PIIQ.
26
Reports of Hepatic function abnormal with POLATUZUMAB VEDOTIN-PIIQ
0.8%
of all POLATUZUMAB VEDOTIN-PIIQ reports
2
Deaths
9
Hospitalizations
How Dangerous Is Hepatic function abnormal From POLATUZUMAB VEDOTIN-PIIQ?
Of the 26 reports, 2 (7.7%) resulted in death, 9 (34.6%) required hospitalization, and 1 (3.8%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POLATUZUMAB VEDOTIN-PIIQ. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does POLATUZUMAB VEDOTIN-PIIQ Cause?
Disease progression (753)
Off label use (484)
Death (367)
Covid-19 (202)
Neutropenia (160)
Pyrexia (119)
Drug ineffective (118)
No adverse event (109)
Blood lactate dehydrogenase increased (108)
Febrile neutropenia (107)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which POLATUZUMAB VEDOTIN-PIIQ Alternatives Have Lower Hepatic function abnormal Risk?
POLATUZUMAB VEDOTIN-PIIQ vs POLIDOCANOL
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL 3350
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM\SODIUM